David M. Rodman

7.8k total citations · 1 hit paper
100 papers, 5.6k citations indexed

About

David M. Rodman is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, David M. Rodman has authored 100 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 46 papers in Physiology and 24 papers in Molecular Biology. Recurrent topics in David M. Rodman's work include Nitric Oxide and Endothelin Effects (38 papers), Pulmonary Hypertension Research and Treatments (30 papers) and Neuroscience of respiration and sleep (14 papers). David M. Rodman is often cited by papers focused on Nitric Oxide and Endothelin Effects (38 papers), Pulmonary Hypertension Research and Treatments (30 papers) and Neuroscience of respiration and sleep (14 papers). David M. Rodman collaborates with scholars based in United States, Germany and France. David M. Rodman's co-authors include Ivan F. McMurtry, Karen A. Fagan, Brian Fouty, Richard F. OʼBrien, Steven H. Abman, James West, Richard H. Simon, Bruce C. Marshall, Beth Sufian and James R. Yankaskas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

David M. Rodman

99 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

2014 336 citations David Waltz, David M. Rodman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Rodman United States	40	3.3k	2.1k	1.6k	1.2k	693	100	5.6k
J. Usha Raj United States	40	3.1k 1.0×	1.0k 0.5×	1.8k 1.1×	976 0.8×	496 0.7×	181	5.3k
Takayuki Kuriyama Japan	38	2.2k 0.7×	1.4k 0.7×	902 0.6×	788 0.7×	858 1.2×	176	4.9k
Bruce D. Uhal United States	40	3.0k 0.9×	548 0.3×	1.4k 0.9×	770 0.7×	255 0.4×	120	5.5k
Natascha Sommer Germany	28	1.6k 0.5×	420 0.2×	730 0.5×	980 0.8×	247 0.4×	113	3.0k
Jesse D. Roberts United States	26	1.9k 0.6×	932 0.5×	413 0.3×	498 0.4×	737 1.1×	52	3.0k
Rory E. Morty Germany	48	3.3k 1.0×	397 0.2×	2.0k 1.3×	351 0.3×	614 0.9×	159	5.8k
Heimo Mairbäurl Germany	34	1.2k 0.4×	579 0.3×	1.1k 0.7×	443 0.4×	1.1k 1.6×	102	4.2k
Tomonobu Koizumi Japan	38	1.9k 0.6×	593 0.3×	1.2k 0.7×	282 0.2×	303 0.4×	303	5.1k
Alan R. Leff United States	35	1.5k 0.5×	1.5k 0.7×	1.1k 0.7×	238 0.2×	122 0.2×	120	4.0k
Sina A. Gharib United States	40	1.6k 0.5×	690 0.3×	1.1k 0.7×	273 0.2×	244 0.4×	132	4.2k

Countries citing papers authored by David M. Rodman

Since Specialization

Citations

This map shows the geographic impact of David M. Rodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Rodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Rodman more than expected).

Fields of papers citing papers by David M. Rodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Rodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Rodman. The network helps show where David M. Rodman may publish in the future.

Co-authorship network of co-authors of David M. Rodman

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Rodman. A scholar is included among the top collaborators of David M. Rodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Rodman. David M. Rodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weir, Matthew R., et al.. (2025). Lorundrostat, a Novel Aldosterone Synthase Inhibitor (ASI), in Participants with Uncontrolled Hypertension, CKD, and Albuminuria: Results from Explore-CKD. Journal of the American Society of Nephrology. 36(10S).

Russell, Stephen R., Arlene V. Drack, Artur V. Cideciyan, et al.. (2020). Results of a phase 1b/2 trial of intravitreal (IVT) sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis 10 (LCA10) due to p.Cys998X mutation in the CEP290 gene. Investigative Ophthalmology & Visual Science. 61(7). 866–866. 3 indexed citations

Rodman, David M., et al.. (2013). The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation. Journal of Cystic Fibrosis. 12(6). 706–713. 17 indexed citations

Nicholson, Grant C., Harsha H. Kariyawasam, Andrew J. Tan, et al.. (2011). The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge. Journal of Allergy and Clinical Immunology. 128(4). 800–807.e9. 44 indexed citations

Saavedra, Milene T., Grant Hughes, Linda Sanders, et al.. (2008). Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 178(9). 929–938. 15 indexed citations

Hagen, Moira, Karen Fagan, Wolfgang Steudel, et al.. (2007). Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(6). L1473–L1479. 129 indexed citations

Rodman, David M., Sonya L. Heltshe, Marci K. Sontag, et al.. (2005). Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 171(6). 621–626. 119 indexed citations

Nick, Jerry A. & David M. Rodman. (2005). Manifestations of cystic fibrosis diagnosed in adulthood. Current Opinion in Internal Medicine. 5(1). 68–73. 28 indexed citations

Lu, Xiaojun, Jack L. Arbiser, James West, et al.. (2004). Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Can Induce Apoptosis in Subsets of Premalignant Cells. American Journal Of Pathology. 165(5). 1613–1620. 14 indexed citations

10.

West, James, et al.. (2004). Adenoviral gene transfer to the neonatal rat pulmonary circulation. The Journal of Gene Medicine. 6(7). 734–739. 1 indexed citations

11.

Hartsfield, Cynthia L., Ivan F. McMurtry, D. Dunbar Ivy, et al.. (2004). Cardioprotective and vasomotor effects of HO activity during acute and chronic hypoxia. American Journal of Physiology-Heart and Circulatory Physiology. 287(5). H2009–H2015. 17 indexed citations

12.

Moss, Richard B., David M. Rodman, L. Terry Spencer, et al.. (2004). Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis. CHEST Journal. 125(2). 509–521. 292 indexed citations

13.

Dickinson, Matthew, et al.. (2002). Chronic mucoid Pseudomonas aeruginosa cholangitis complicating ERCP in a CF patient. Journal of Cystic Fibrosis. 1(2). 99–101. 2 indexed citations

14.

Hengstschläger, Markus, et al.. (2001). Tuberous sclerosis gene products in proliferation control. Mutation Research/Reviews in Mutation Research. 488(3). 233–239. 46 indexed citations

15.

Fagan, Karen A., Brian Morrissey, Brian Fouty, et al.. (2001). Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension. Respiratory Research. 2(5). 306–13. 80 indexed citations

16.

Fagan, Karen A., Brian Fouty, Robert Claude Tyler, et al.. (1999). The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. Journal of Clinical Investigation. 103(2). 291–299. 253 indexed citations

17.

Tyler, Robert Claude, Clayton Bullock, Cori Gorman, et al.. (1997). Polycationic Lipid-Mediated Gene Transfer to the Abnormal Pulmonary Circulation. CHEST Journal. 111(6). 122S–123S. 3 indexed citations

18.

Rodman, David M., et al.. (1991). Difference in Effect of Inhibitors of Energy Metabolism on Endothelium-dependent Relaxation of Rat Pulmonary Artery and Aorta. American Journal of Respiratory Cell and Molecular Biology. 4(3). 237–242. 14 indexed citations

19.

Rodman, David M., et al.. (1991). Effects of K ⁺ Channel Blockers on Vascular Tone in the Perfused Rat Lung. American Review of Respiratory Disease. 144(4). 884–887. 90 indexed citations

20.

Rodman, David M. & JoAnn Lindenfeld. (1990). Successful Treatment of Sarcoidosis-Associated Pulmonary Hypertension with Corticosteroids. CHEST Journal. 97(2). 500–502. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact